{"id": "2146", "gene": "SMAD4", "evidence_items": ["Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-63.", "https://www.ncbi.nlm.nih.gov/clinvar/variation/41788/"], "pmkb_evidence_tier": "3", "variants": [{"name": "SMAD4 I525V", "id": "2839"}], "diseases": ["Astrocytoma, NOS", "Glioblastoma", "Astrocytoma, Anaplastic"], "therapies": ["therapeutic procedure"], "description": "SMAD4 is tumor suppressor gene and it encodes an intracellular mediator in the transforming growth factor b (TGF b) signal transduction pathway. Somatic mutations in SMAD4 are exceedingly rare in glial neoplasms. SMAD4 I525V has been reported as a likely benign germline variant in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/41788/). These results should be interpreted in the clinical context.", "tissue_types": ["Brain"]}